CTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Captor Therapeutics SA

Watchlist Manager

Watchlist

Price: 77 PLN -0.26% Market Closed

Market Cap: zł489m

C	Captor Therapeutics SA WSE:CTX	PL
	Sasken Technologies Ltd NSE:SASKEN	IN
N	Nedbank Group Ltd JSE:NED	ZA
Y	Ypsomed Holding AG XMUN:OWX	CH
	Lynas Rare Earths Ltd XMUN:LYI	AU
S	SugarBud Craft Growers Corp F:REL	CA
	LendLease Group ASX:LLC	AU
	Sirius XM Holdings Inc NASDAQ:SIRI	US

Profitability Summary

Captor Therapeutics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

62%

Declining Gross Margin

77% > 48%

Negative Operating Margin

-363%

Negative 3Y Average Operating Margin

-385%

Operating Margin is Increasing

-445% > -363%

Negative Net Margin

-353%

Negative 3Y Average Net Margin

-372%

Net Margin is Increasing

-405% > -353%

Negative Free Cash Flow Margin

-26%

Negative 3Y Average Free Cash Flow Margin

-237%

Free Cash Flow Margin is Increasing

-266% > -26%

Negative ROE

-82%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-373%

ROIC is Increasing

-319% > -115%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.